In our latest podcast episode, I sit down with Modular Medical CEO Jeb Besser to dig into what makes MODD-1 different: how it breaks insulin delivery into two parts, who it’s built for, and why it could become a real game-changer in the diabetes tech space.

MODD-1 isn’t just another pump. It’s designed as a modular, two-part system that separates the computing/controller module from the insulin reservoir and delivery module. This means you might be able to upgrade one piece (say, the controller with a better algorithm) without throwing away the entire pump. That modular flexibility can reduce waste, cost, and upgrade barriers.

Another standout: the modular design opens up possibilities for customization. Users could mix and match components — a high-capacity reservoir with a basic controller, or later swap in a more advanced module when new features come out. Think of it like your smartphone: keep the body, upgrade the brain.

During our conversation, Jeb and I traced the pump’s origins — from prototype to FDA clearance — and talked about how the modular architecture helps with maintenance and service. He also shared who MODD-1 is aimed at: people who want future-proof tech, reduced replacement waste, and more control over their device upgrades.

Of course, performance matters just as much as design. While MODD-1 is heading toward its public release in early 2026, early reviews suggest it handles standard pump functionality well — basal delivery, bolus, safety checks — but also allows room for algorithmic growth later on.

Want to see how the modular pieces snap together and hear Jeb’s vision of where pump therapy is headed? Watch the full episode below, or listen to the podcast above.

Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a physician before making changes to your healthcare.